AstraZeneca Seeks To Block Ex-Consultant's Testimony

Law360, New York (March 10, 2011, 3:19 PM EST) -- AstraZeneca Pharmaceuticals Inc. moved Wednesday to block a rival from using one of its paid consultants as an expert witness in ongoing patent infringement litigation in New Jersey over a proposed generic version of schizophrenia treatment Seroquel XR.

AstraZeneca filed a motion in the U.S. District Court for the District of New Jersey to disqualify Dr. Christopher Reist from testifying for Handa Pharmaceuticals LLC, arguing his confidential work with AstraZeneca created a conflict of interest and would unfairly prejudice the plaintiff.

Reist worked on the clinical...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.